Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
University of California, San Francisco
University of California, San Francisco
QuantumLeap Healthcare Collaborative
Centre Leon Berard
Angiex, Inc.
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Herlev and Gentofte Hospital